Esoteric Testing Market Worth $36.3 Bn By 2026 — Exclusive Report By Marketsandmarkets

By Author: Johnny
Total Articles: 114
Comment this article

Global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period according to a new report by MarketsandMarkets™. Emerging markets in Asian countries are expected to provide strong growth opportunities for market players.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76794708

Browse in-depth TOC on " Esoteric Testing”

134 - Tables

47 - Figures

244 - Pages

infectious diseases accounted for the largest share of the esoteric testing market. The genetic testing segment is expected to grow at the highest CAGR during the forecast period.

Based on the type, the esoteric testing market is segmented into infectious disease testing, endocrinology testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and other testing. the infectious disease testing segment accounted the largest share of the esoteric testing market

CLIA segment account for the largest share of the esoteric testing market.

Based ...
... on technology, esoteric testing market is segmented into chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), mass spectrometry, real-time PCR, flow cytometry, DNA sequencing, and other technologies. CLIA accounted for the largest share of the esoteric testing market.

Independent & reference laboratories account for the largest share of the esoteric testing market

Based on end user, the esoteric testing market is segmented into independent & reference laboratories and hospital-based laboratories. Independent & reference laboratories account for the largest share of the esoteric testing market.

Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=76794708

North America was the largest regional market for the esoteric testing market

North America was the largest regional market for esoteric testing market. The large share of the North American market can be attributed to the increasing per capita healthcare expenditure, presence of the leading market players, increasing use of rapid diagnostics, expanding geriatric population, and advancing precision medicine in the region.

Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. Emerging APAC economies such as China and India are expected to see significant growth due their advancing healthcare infrastructure, increasing penetration of cutting-edge clinical laboratories, and expanding geriatric population are the major factors driving the growth of this market.

The global esoteric testing market is consolidated. The prominent players operating in this market include Labcorp (US), Quest Diagnostics (US) and OPKO Health Inc. (US).

Get 10% Free Customization on this Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=76794708

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.